Next Generation News and Research

RSS

Imaxio Sells Genomics Division To Hybrigenics

...

16 Oct 2013

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Zydus Cadila, an innovative global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare products, and Pieris AG, a next generation therapeutic protein R&D company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics, both companies announced today.

16 Oct 2013

Two institutions receive $25M grant from NIH to abet clinical and translational research

Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $25 million grant from the National Institutes of Health (NIH) for the Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at Einstein and Montefiore.

16 Oct 2013

Astrazeneca Acquires Spirogen For Up To $440M

...

15 Oct 2013

Affiliate of Channel Technologies Group buys assets of H.C. Materials

An affiliate of Channel Technologies Group, LLC, a manufacturer of piezoelectric ceramics, transducers and complex sonar and navigation systems used in the defense, medical and energy industries, today announced it has acquired the assets of H.C. Materials Inc. and its affiliates (collectively, "HCM") from Dr. Pengdi Han.

12 Oct 2013

Olympus launches forward-viewing curvilinear ultrasound gastrovideoscope

Olympus, a precision technology leader in designing and delivering innovative solutions in the medical and surgical field, among other core businesses, announced today the launch of its 510(k) cleared and world's only forward-viewing curvilinear ultrasound gastrovideoscope.

From Evident Corporation - Life Sciences 10 Oct 2013

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.

10 Oct 2013

Catalyst, Isu Abxis To Develop Hemophilia B Candidate

...

9 Oct 2013

Most mobile apps lack behavioral weight-loss strategies

In a new study published by the American Journal of Preventive Medicine, UMass Medical School behavioral psychologist and weight loss expert Sherry Pagoto, PhD, and colleagues find that mobile apps to help people lose weight are lacking when it comes to strategies for changing behaviors.

9 Oct 2013

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

The recognition of a causal link between mutations in BRCA1 and BRCA2 genes and increased risk of developing breast and ovarian cancer has intensified the demand for genetic testing. Identifying mutations in these large genes by conventional methods can be time consuming and costly.

9 Oct 2013

Study: Distinct behavior of proteins reflects common biochemical principles

Researchers from Case Western Reserve University School of Medicine have found unexpected similarities between proteins that were thought to be fundamentally different.

9 Oct 2013

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.

9 Oct 2013

Brain & Behavior Research Foundation to hold research symposium on mental health

The Brain & Behavior Research Foundation, an organization dedicated to improving the lives of those with mental illness through the transformative power of neuroscience and psychiatric research, will hold its 25th Annual Mental Health Research Symposium on Friday, October 25th from 9:00 am to 4:30 p.m. at the Kaufman Music Center, located at 129 W. 67th St. in New York City.

8 Oct 2013

Vaccination campaign led HBV to more than double rate of "breakout" mutations

A universal infant vaccination campaign in China has led the Hepatitis B virus (HBV) to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies.

8 Oct 2013

Researchers discover way to use stem cells as drug delivery vehicles

A group of Brigham and Women's Hospital, and Harvard Stem Cell Institute researchers and collaborators at MIT and MGH have found a way to use stem cells as drug delivery vehicles.

5 Oct 2013

Cynvenio launches ClearID Breast Cancer monitoring program

Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.

4 Oct 2013

Excessive weight gain during pregnancy may have significant effect on future obesity among children

A study of 41,133 mothers and their children in Arkansas shows that high pregnancy weight gain increases the risk of obesity in those children through age 12. The findings, published Oct. 1 in PLoS Medicine by Princeton University, suggest pregnancy may be an especially important time to prevent obesity in the next generation.

3 Oct 2013

SDSC receives $12M grant to deploy Comet to extend computational resources to diversified user base

The San Diego Supercomputer Center (SDSC) at the University of California, San Diego, has been awarded a $12-million grant from the National Science Foundation (NSF) to deploy Comet, a new petascale supercomputer designed to transform advanced scientific computing by expanding access and capacity among traditional as well as non-traditional research domains.

3 Oct 2013

Ilesto ICD/CRT-D devices from BIOTRONIK approved by FDA

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced it has received approval from the Food and Drug Administration (FDA) for its Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices). BIOTRONIK follows this milestone with the launch of its next generation unique technology platform Ilesto DX.

1 Oct 2013

Merck & Co. Axes 8,500 In R&D Restructuring

...

1 Oct 2013

Next Generation News and Research

Imaxio Sells Genomics Division To Hybrigenics

Pieris, Zydus Cadila partner to develop and commercialize Anticalin-based protein therapeutics

Two institutions receive $25M grant from NIH to abet clinical and translational research

Astrazeneca Acquires Spirogen For Up To $440M

Affiliate of Channel Technologies Group buys assets of H.C. Materials

Olympus launches forward-viewing curvilinear ultrasound gastrovideoscope

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Catalyst, Isu Abxis To Develop Hemophilia B Candidate

Most mobile apps lack behavioral weight-loss strategies

Next-generation sequencing technology effective for detecting BRCA1 and BRCA2 mutations

Study: Distinct behavior of proteins reflects common biochemical principles

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

Brain & Behavior Research Foundation to hold research symposium on mental health

Vaccination campaign led HBV to more than double rate of "breakout" mutations

Researchers discover way to use stem cells as drug delivery vehicles

Cynvenio launches ClearID Breast Cancer monitoring program

Excessive weight gain during pregnancy may have significant effect on future obesity among children

SDSC receives $12M grant to deploy Comet to extend computational resources to diversified user base

Ilesto ICD/CRT-D devices from BIOTRONIK approved by FDA

Merck & Co. Axes 8,500 In R&D Restructuring

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News